Related Experiment Videos
Antibiotics after rattlesnake envenomation
Frank LoVecchio1, Jane Klemens, Sharon Welch
1Good Samaritan Regional Medical and Poison Control Center, Department of Medical Toxicology, Phoenix, Arizona 85006, USA.
The Journal of Emergency Medicine
|December 14, 2002
Summary
This study found no infections in rattlesnake bite patients who did not receive prophylactic antibiotics. Therefore, routine antibiotic use is not recommended for rattlesnake bites (RSBs).
Area of Science:
- Toxicology
- Infectious Disease
- Emergency Medicine
Background:
- Rattlesnake bites (RSBs) can lead to serious complications, including infection.
- The use of prophylactic antibiotics in RSB management is debated.
- Evidence is needed to guide antibiotic prescribing practices for RSBs.
Purpose of the Study:
- To determine the infection rate in patients with rattlesnake bites (RSBs) who did not receive prophylactic antibiotics.
- To evaluate the necessity of routine antibiotic administration in RSB cases.
Main Methods:
- A prospective observational study was conducted over 18 months.
- Fifty-six patients with RSBs treated within 24 hours were enrolled.
- Follow-up was completed 7-10 days post-envenomation via various methods.
Main Results:
- Of 53 patients completing the study, none developed documented infections.
- Most patients (81%) received antivenom; common symptoms included swelling and lymphadenopathy.
- A small percentage (6%) received antibiotics later from primary care physicians without subsequent infection.
Conclusions:
- Prophylactic antibiotics are not indicated for patients with rattlesnake bites.
- Current findings suggest a low risk of infection in RSB patients managed without routine antibiotics.
- This study supports a conservative approach to antibiotic use in RSB management.